NTR vs. BMY
Compare and contrast key facts about Nutrien Ltd. (NTR) and Bristol-Myers Squibb Company (BMY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NTR or BMY.
Performance
NTR vs. BMY - Performance Comparison
Returns By Period
In the year-to-date period, NTR achieves a -16.12% return, which is significantly lower than BMY's 15.11% return.
NTR
-16.12%
-4.01%
-22.01%
-15.65%
3.18%
N/A
BMY
15.11%
5.64%
31.08%
16.17%
3.51%
2.74%
Fundamentals
| NTR | BMY | |
|---|---|---|
| Market Cap | $23.21B | $121.33B |
| EPS | $1.48 | -$3.53 |
| PEG Ratio | 1.15 | 2.20 |
| Total Revenue (TTM) | $25.67B | $47.44B |
| Gross Profit (TTM) | $7.35B | $33.40B |
| EBITDA (TTM) | $3.19B | $18.32B |
Key characteristics
| NTR | BMY | |
|---|---|---|
| Sharpe Ratio | -0.61 | 0.51 |
| Sortino Ratio | -0.77 | 1.01 |
| Omega Ratio | 0.92 | 1.12 |
| Calmar Ratio | -0.29 | 0.30 |
| Martin Ratio | -1.24 | 1.26 |
| Ulcer Index | 13.40% | 11.52% |
| Daily Std Dev | 27.49% | 28.61% |
| Max Drawdown | -57.51% | -70.62% |
| Current Drawdown | -56.54% | -24.61% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between NTR and BMY is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
NTR vs. BMY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Nutrien Ltd. (NTR) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NTR vs. BMY - Dividend Comparison
NTR's dividend yield for the trailing twelve months is around 4.70%, more than BMY's 4.27% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NTR Nutrien Ltd. | 4.70% | 3.76% | 2.63% | 2.45% | 3.74% | 3.67% | 3.47% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
BMY Bristol-Myers Squibb Company | 4.27% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% | 2.46% | 3.31% |
Drawdowns
NTR vs. BMY - Drawdown Comparison
The maximum NTR drawdown since its inception was -57.51%, smaller than the maximum BMY drawdown of -70.62%. Use the drawdown chart below to compare losses from any high point for NTR and BMY. For additional features, visit the drawdowns tool.
Volatility
NTR vs. BMY - Volatility Comparison
The current volatility for Nutrien Ltd. (NTR) is 7.85%, while Bristol-Myers Squibb Company (BMY) has a volatility of 13.64%. This indicates that NTR experiences smaller price fluctuations and is considered to be less risky than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
NTR vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between Nutrien Ltd. and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities